153 related articles for article (PubMed ID: 15813034)
1. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].
Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q
Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
3. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
4. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
[TBL] [Abstract][Full Text] [Related]
6. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats.
Wang XQ; Dai JD; Zhang H; Zhang X; Wang JC; Zhang Q
J Nanosci Nanotechnol; 2008 May; 8(5):2422-31. PubMed ID: 18572658
[TBL] [Abstract][Full Text] [Related]
7. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
[TBL] [Abstract][Full Text] [Related]
8. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Dai W; Guo Y; Zhang H; Wang X; Zhang Q
Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562
[TBL] [Abstract][Full Text] [Related]
9. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
[TBL] [Abstract][Full Text] [Related]
11. [Study on preparation conditions for polylactide nanoparticles loaded cyclosporine A and its oral bioavailability in rats].
Wang XQ; Zhang T; He Y; Zhang L; Zhang Q
Yao Xue Xue Bao; 2004 Jan; 39(1):68-71. PubMed ID: 15127586
[TBL] [Abstract][Full Text] [Related]
12. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Anderson IF; Helve T; Hannonen P; Leirisalo-Repo M; Gilboe IM; Nissilä M; Keystone EC; Kraag GR; Bjørneboe O; Chalmers A; Dovland H; Mueller E; Richard F; Whatmough I; Schmidt AG; Kovarik JM
J Rheumatol; 1999 Mar; 26(3):556-62. PubMed ID: 10090162
[TBL] [Abstract][Full Text] [Related]
13. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
[TBL] [Abstract][Full Text] [Related]
14. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral.
Kees F; Mair G; Dittmar M; Bucher M
Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736
[TBL] [Abstract][Full Text] [Related]
15. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
[TBL] [Abstract][Full Text] [Related]
16. [Influence of suspending agents on relative bioavailability of cyclosporine A-loaded HPMCP nanoparticles for oral administration to rats].
Wang XQ; Chen Z; Dai JD; Zhang T; Xia GM; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):305-8. PubMed ID: 15205706
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.
Zhang Y; Li X; Zhou Y; Fan Y; Wang X; Huang Y; Liu Y
Mol Pharm; 2010 Aug; 7(4):1169-82. PubMed ID: 20540526
[TBL] [Abstract][Full Text] [Related]
18. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
19. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Orally Administered Poly(Ethylene Oxide)-block-Poly(ε-Caprolactone) Micelles of Cyclosporine A in Rats: Comparison with Neoral®.
Binkhathlan Z; Ali R; Qamar W; Lavasanifar A
J Pharm Pharm Sci; 2018; 21(1s):192s-199s. PubMed ID: 30139426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]